Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 68

1.

Melatonin for the management of sleep problems in children with neurodevelopmental disorders: a systematic review and meta-analysis.

Abdelgadir IS, Gordon MA, Akobeng AK.

Arch Dis Child. 2018 May 2. pii: archdischild-2017-314181. doi: 10.1136/archdischild-2017-314181. [Epub ahead of print]

PMID:
29720494
2.

Clinical usefulness of the faecal calprotectin test in suspected paediatric inflammatory bowel disease.

Akobeng AK.

Acta Paediatr. 2018 Apr 29. doi: 10.1111/apa.14374. [Epub ahead of print]

PMID:
29706011
3.

Patent foramen ovale (PFO) closure versus medical therapy for prevention of recurrent stroke in patients with prior cryptogenic stroke: A systematic review and meta-analysis of randomized controlled trials.

Akobeng AK, Abdelgadir I, Boudjemline Y, Hijazi ZM.

Catheter Cardiovasc Interv. 2018 Mar 30. doi: 10.1002/ccd.27615. [Epub ahead of print]

PMID:
29602258
4.

Corticosteroids for Preventing Caustic Esophageal Strictures: Systematic Review and Meta-analysis.

Katibe R, Abdelgadir I, McGrogan P, Akobeng AK.

J Pediatr Gastroenterol Nutr. 2018 Jun;66(6):898-902. doi: 10.1097/MPG.0000000000001852.

PMID:
29216023
5.

Oral 5-aminosalicylic acid for maintenance of medically-induced remission in Crohn's disease.

Akobeng AK, Zhang D, Gordon M, MacDonald JK.

Cochrane Database Syst Rev. 2016 Sep 28;9:CD003715. doi: 10.1002/14651858.CD003715.pub3. Review.

PMID:
27681657
6.

Osmotic and stimulant laxatives for the management of childhood constipation.

Gordon M, MacDonald JK, Parker CE, Akobeng AK, Thomas AG.

Cochrane Database Syst Rev. 2016 Aug 17;(8):CD009118. doi: 10.1002/14651858.CD009118.pub3. Review.

PMID:
27531591
7.

Understanding type I and type II errors, statistical power and sample size.

Akobeng AK.

Acta Paediatr. 2016 Jun;105(6):605-9. doi: 10.1111/apa.13384. Epub 2016 Mar 31. Review.

PMID:
26935977
8.

Glutamine for induction of remission in Crohn's disease.

Akobeng AK, Elawad M, Gordon M.

Cochrane Database Syst Rev. 2016 Feb 8;2:CD007348. doi: 10.1002/14651858.CD007348.pub2. Review.

PMID:
26853855
9.

Telephone Consultation as a Substitute for Routine Out-patient Face-to-face Consultation for Children With Inflammatory Bowel Disease: Randomised Controlled Trial and Economic Evaluation.

Akobeng AK, O'Leary N, Vail A, Brown N, Widiatmoko D, Fagbemi A, Thomas AG.

EBioMedicine. 2015 Aug 8;2(9):1251-6. doi: 10.1016/j.ebiom.2015.08.011. eCollection 2015 Sep.

10.

Azathioprine and 6-mercaptopurine for maintenance of surgically-induced remission in Crohn's disease.

Gordon M, Taylor K, Akobeng AK, Thomas AG.

Cochrane Database Syst Rev. 2014 Aug 1;(8):CD010233. doi: 10.1002/14651858.CD010233.pub2. Review.

PMID:
25081347
11.

Cochrane Review: Osmotic and stimulant laxatives for the management of childhood constipation (Review).

Gordon M, Naidoo K, Akobeng AK, Thomas AG.

Evid Based Child Health. 2013 Jan;8(1):57-109. doi: 10.1002/ebch.1893. Review.

PMID:
23878124
12.

Osmotic and stimulant laxatives for the management of childhood constipation.

Gordon M, Naidoo K, Akobeng AK, Thomas AG.

Cochrane Database Syst Rev. 2012 Jul 11;(7):CD009118. doi: 10.1002/14651858.CD009118.pub2. Review. Update in: Cochrane Database Syst Rev. 2016;8:CD009118.

PMID:
22786523
13.

The effects of anti-TNF-α treatment with adalimumab on growth in children with Crohn's disease (CD).

Malik S, Ahmed SF, Wilson ML, Shah N, Loganathan S, Naik S, Bourke B, Thomas A, Akobeng AK, Fagbemi A, Wilson DC, Russell RK.

J Crohns Colitis. 2012 Apr;6(3):337-44. doi: 10.1016/j.crohns.2011.09.004. Epub 2011 Oct 15.

PMID:
22405171
14.

Probiotics for maintenance of remission in ulcerative colitis.

Naidoo K, Gordon M, Fagbemi AO, Thomas AG, Akobeng AK.

Cochrane Database Syst Rev. 2011 Dec 7;(12):CD007443. doi: 10.1002/14651858.CD007443.pub2. Review.

PMID:
22161412
15.

Efficacy of 5-aminosalicylates for the maintenance of remission in Crohn's disease.

Akobeng AK.

Am J Gastroenterol. 2011 Oct;106(10):1857; author reply 1857-8. doi: 10.1038/ajg.2011.217. No abstract available.

PMID:
21979212
16.

Validation of an instrument to measure quality of life in British children with inflammatory bowel disease.

Ogden CA, Akobeng AK, Abbott J, Aggett P, Sood MR, Thomas AG.

J Pediatr Gastroenterol Nutr. 2011 Sep;53(3):280-6. doi: 10.1097/MPG.0b013e3182165d10.

PMID:
21865975
17.

A British Society of Paediatric Gastroenterology, Hepatology and Nutrition survey of the effectiveness and safety of adalimumab in children with inflammatory bowel disease.

Russell RK, Wilson ML, Loganathan S, Bourke B, Kiparissi F, Mahdi G, Torrente F, Rodrigues A, Davies I, Thomas A, Akobeng AK, Fagbemi A, Hyer W, Spray C, Vaish S, Rogers P, McGrogan P, Heuschkel RB, Ayub N, Fell JM, Afzal NA, Green M, Murphy MS, Rao P, Shah N, Ho GT, Naik S, Wilson DC.

Aliment Pharmacol Ther. 2011 Apr;33(8):946-53. doi: 10.1111/j.1365-2036.2011.04603.x. Epub 2011 Feb 22.

18.

Oral 5-aminosalicylic acid for maintenance of surgically-induced remission in Crohn's disease.

Gordon M, Naidoo K, Thomas AG, Akobeng AK.

Cochrane Database Syst Rev. 2011 Jan 19;(1):CD008414. doi: 10.1002/14651858.CD008414.pub2. Review.

PMID:
21249709
19.

Severe hypokalemia due to an inappropriate formula milk.

Osuagwu MN, Gordon M, Akobeng AK.

Clin Pediatr (Phila). 2012 Jan;51(1):86-7. doi: 10.1177/0009922810389171. Epub 2010 Dec 6. No abstract available.

PMID:
21138850
20.

Refeeding syndrome following exclusive enteral nutritional treatment in Crohn disease.

Akobeng AK, Thomas AG.

J Pediatr Gastroenterol Nutr. 2010 Sep;51(3):364-6. doi: 10.1097/MPG.0b013e3181e712d6. No abstract available.

PMID:
20639770
21.

Systematic review of the evidence base for the medical treatment of paediatric inflammatory bowel disease.

Wilson DC, Thomas AG, Croft NM, Newby E, Akobeng AK, Sawczenko A, Fell JM, Murphy MS, Beattie RM, Sandhu BK, Mitton SG; IBD Working Group of the British Society of Paediatric Gastroenterology, Hepatology, and Nutrition, Casson D, Elawad M, Heuschkel R, Jenkins H, Johnson T, Macdonald S, Murch SH.

J Pediatr Gastroenterol Nutr. 2010 Feb;50 Suppl 1:S14-34. doi: 10.1097/MPG.0b013e3181c92caa. Review.

PMID:
20081542
22.

Thalidomide and thalidomide analogues for maintenance of remission in Crohn's disease.

Akobeng AK, Stokkers PC.

Cochrane Database Syst Rev. 2009 Apr 15;(2):CD007351. doi: 10.1002/14651858.CD007351.pub2. Review.

PMID:
19370685
23.

Thalidomide and thalidomide analogues for induction of remission in Crohn's disease.

Srinivasan R, Akobeng AK.

Cochrane Database Syst Rev. 2009 Apr 15;(2):CD007350. doi: 10.1002/14651858.CD007350.pub2. Review.

PMID:
19370684
24.

Assessing the validity of clinical trials.

Akobeng AK.

J Pediatr Gastroenterol Nutr. 2008 Sep;47(3):277-82. doi: 10.1097/MPG.0b013e31816c749f. Review.

PMID:
18728521
25.

Probiotics for induction of remission in Crohn's disease.

Butterworth AD, Thomas AG, Akobeng AK.

Cochrane Database Syst Rev. 2008 Jul 16;(3):CD006634. doi: 10.1002/14651858.CD006634.pub2. Review.

PMID:
18646162
26.

Anti-mycobacterials and Crohn's disease: author's reply.

Akobeng AK.

Aliment Pharmacol Ther. 2008 Aug 1;28(3):374-5. No abstract available.

27.

Confidence intervals and p-values in clinical decision making.

Akobeng AK.

Acta Paediatr. 2008 Aug;97(8):1004-7. doi: 10.1111/j.1651-2227.2008.00836.x. Epub 2008 May 7.

PMID:
18462462
28.

Crohn's disease: current treatment options.

Akobeng AK.

Arch Dis Child. 2008 Sep;93(9):787-92. doi: 10.1136/adc.2007.128751. Epub 2008 May 2. Review.

PMID:
18456695
29.

Communicating the benefits and harms of treatments.

Akobeng AK.

Arch Dis Child. 2008 Aug;93(8):710-3. doi: 10.1136/adc.2008.137083. Epub 2008 May 2. Review.

PMID:
18456681
30.

Vitamin D supplementation in early childhood and risk of type 1 diabetes: a systematic review and meta-analysis.

Zipitis CS, Akobeng AK.

Arch Dis Child. 2008 Jun;93(6):512-7. doi: 10.1136/adc.2007.128579. Epub 2008 Mar 13. Review.

PMID:
18339654
31.

Systematic review: tolerable amount of gluten for people with coeliac disease.

Akobeng AK, Thomas AG.

Aliment Pharmacol Ther. 2008 Jun 1;27(11):1044-52. doi: 10.1111/j.1365-2036.2008.03669.x. Epub 2008 Feb 29. Review.

32.

Adalimumab for maintenance of clinical response and remission in patients with Crohn's disease: the CHARM trial. Colombel JF, Sandborn WJ, Rutgeerts P et al. Gastroenterology 2007;132:52-65.

Jilani NZ, Akobeng AK.

J Pediatr Gastroenterol Nutr. 2008 Feb;46(2):226-7. doi: 10.1097/MPG.0b013e318156e139. No abstract available.

PMID:
18223389
33.

Review article: the evidence base for interventions used to maintain remission in Crohn's disease.

Akobeng AK.

Aliment Pharmacol Ther. 2008 Jan 1;27(1):11-8. Epub 2007 Oct 5. Review.

34.

Enteral nutrition for maintenance of remission in Crohn's disease.

Akobeng AK, Thomas AG.

Cochrane Database Syst Rev. 2007 Jul 18;(3):CD005984. Review.

PMID:
17636816
35.
36.

Understanding diagnostic tests 3: Receiver operating characteristic curves.

Akobeng AK.

Acta Paediatr. 2007 May;96(5):644-7. Epub 2007 Mar 21. Review.

PMID:
17376185
37.
38.

Effect of exclusive enteral nutritional treatment on plasma antioxidant concentrations in childhood Crohn's disease.

Akobeng AK, Richmond K, Miller V, Thomas AG.

Clin Nutr. 2007 Feb;26(1):51-6. Epub 2006 Dec 11.

PMID:
17161887
39.

Tumour necrosis factor alpha blocking agents for induction of remission in ulcerative colitis.

Lawson MM, Thomas AG, Akobeng AK.

Cochrane Database Syst Rev. 2006 Jul 19;(3):CD005112. Review.

PMID:
16856078
40.
41.

Infliximab for induction and maintenance therapy for ulcerative colitis.

Akobeng AK.

J Pediatr Gastroenterol Nutr. 2006 May;42(5):589-90. No abstract available.

PMID:
16707988
42.

Effect of breast feeding on risk of coeliac disease: a systematic review and meta-analysis of observational studies.

Akobeng AK, Ramanan AV, Buchan I, Heller RF.

Arch Dis Child. 2006 Jan;91(1):39-43. Epub 2005 Nov 15. Review.

43.

Evidence in practice.

Akobeng AK.

Arch Dis Child. 2005 Aug;90(8):849-52.

44.

Understanding systematic reviews and meta-analysis.

Akobeng AK.

Arch Dis Child. 2005 Aug;90(8):845-8.

45.

Understanding randomised controlled trials.

Akobeng AK.

Arch Dis Child. 2005 Aug;90(8):840-4.

46.

Principles of evidence based medicine.

Akobeng AK.

Arch Dis Child. 2005 Aug;90(8):837-40.

47.

Inverted appendix mistaken for a polyp during colonoscopy and leading to intussusception.

Ram AD, Peckham C, Akobeng AK, Thomas AG, David TJ, Patel L.

J Cyst Fibros. 2005 Sep;4(3):203-4.

48.

Growth in children with Helicobacter pylori infection and dyspepsia.

Sood MR, Joshi S, Akobeng AK, Mitchell J, Thomas AG.

Arch Dis Child. 2005 Oct;90(10):1025-8. Epub 2005 Jun 14.

49.

Oral 5-aminosalicylic acid for maintenance of medically-induced remission in Crohn's Disease.

Akobeng AK, Gardener E.

Cochrane Database Syst Rev. 2005 Jan 25;(1):CD003715. Review.

PMID:
15674913
50.

Understanding measures of treatment effect in clinical trials.

Akobeng AK.

Arch Dis Child. 2005 Jan;90(1):54-6. Review.

Supplemental Content

Loading ...
Support Center